Evidence map›Paper›PMID 33429394›Full record

Observational studyGerontology2021

Residence, Clinical Features, and Genetic Risk Factors Associated with Symptoms of COVID-19 in a Cohort of Older People in Madrid.

Teodoro Del Ser, Miguel A Fernández-Blázquez, Meritxell Valentí, María Ascensión Zea-Sevilla, Belén Frades, Eva Alfayate, Laura Saiz, Olga Calero, Fernando José García-López, Alberto Rábano and 2 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Gerontology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 4 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 4 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Apolipoprotein E and viral infection: Risks and Mechanisms.Molecular therapy. Nucleic acids · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. The relationship of early- and late-onset Alzheimer's disease genes with COVID-19.Journal of neural transmission (Vienna, Austria : 1996) · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Host polymorphisms and COVID-19 infection.Advances in clinical chemistry · 2022
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Teodoro Del SerAlzheimer's Disease Investigation Research Unit, CIEN Foundation, Institute of Health Carlos III, Queen Sofia Foundation Alzheimer Research Center, Madrid, Spain.
Miguel A Fernández-BlázquezAlzheimer's Disease Investigation Research Unit, CIEN Foundation, Institute of Health Carlos III, Queen Sofia Foundation Alzheimer Research Center, Madrid, Spain.
Meritxell ValentíAlzheimer's Disease Investigation Research Unit, CIEN Foundation, Institute of Health Carlos III, Queen Sofia Foundation Alzheimer Research Center, Madrid, Spain.
María Ascensión Zea-SevillaAlzheimer's Disease Investigation Research Unit, CIEN Foundation, Institute of Health Carlos III, Queen Sofia Foundation Alzheimer Research Center, Madrid, Spain.
Belén FradesAlzheimer's Disease Investigation Research Unit, CIEN Foundation, Institute of Health Carlos III, Queen Sofia Foundation Alzheimer Research Center, Madrid, Spain.
Eva AlfayateAlzheimer's Disease Investigation Research Unit, CIEN Foundation, Institute of Health Carlos III, Queen Sofia Foundation Alzheimer Research Center, Madrid, Spain.
Laura SaizAlzheimer's Disease Investigation Research Unit, CIEN Foundation, Institute of Health Carlos III, Queen Sofia Foundation Alzheimer Research Center, Madrid, Spain.
Olga CaleroCentro de Investigación Biomédica en Red sobre Enfermedades Degenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Fernando José García-LópezNational Epidemiology Centre, Institute of Health Carlos III, Madrid, Spain.
Alberto RábanoAlzheimer's Disease Investigation Research Unit, CIEN Foundation, Institute of Health Carlos III, Queen Sofia Foundation Alzheimer Research Center, Madrid, Spain.
Miguel MedinaAlzheimer's Disease Investigation Research Unit, CIEN Foundation, Institute of Health Carlos III, Queen Sofia Foundation Alzheimer Research Center, Madrid, Spain.
Miguel CaleroAlzheimer's Disease Investigation Research Unit, CIEN Foundation, Institute of Health Carlos III, Queen Sofia Foundation Alzheimer Research Center, Madrid, Spain, mcalero@fundacioncien.es.
Instituto de Salud Carlos III · ESFundacion Centro De Investigacion De Enfermedades Neurologicas · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESCentro de Investigación Biomédica en Red · ESCentro Nacional de Epidemiología · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe older population has been especially affected by the severe acute respiratory syndrome coronavirus 2 pandemic (COVID-19).

objectiveThe aim of the study was to explore the incidence, severity, mortality rate, clinical features, and risk factors of symptoms of COVID-19 in home-dwelling older people, and its association with type of residence, cognitive deterioration, and neurodegenerative diseases.

methodsData about symptoms of COVID-19 were collected through a telephone survey in the cohort of 913 older volunteers of the Vallecas Project, aged 75-90 years, most of them (902) home-dwelling, in Madrid, Spain. The association of demographic and anthropometric measures, genetic polymorphisms, comorbidities, life habits, type of residence, and frailty surrogates were explored as potential risk factors for the incidence, severity, and mortality of COVID-19 in the older population.

findingsSixty-two cases reported symptoms compatible with COVID-19; 6 of them had died, 4 in their home and 2 in the nursing home. Moderate/severe cases were significantly older and more frequently males. The APOE ε4 allele was associated with the presence of symptoms of COVID-19. Higher systolic blood pressure, more intense smoking habit, more alcohol intake, lower consumption of coffee and tea, and cognitive impairment were associated with disease severity.

conclusionsThe estimated incidence of symptomatic COVID-19 in this older cohort of Madrid was 6.8%, with an overall mortality rate of 0.7% (18.2% in those living in a nursing home) and a fatality rate of 9.9%. Our exploratory study indicates that life habits, other clinical conditions and, the ε4 variant of the APOE gene are associated with the presence and clinical severity of coronavirus infection.

Indexed as

Independent LivingNursing HomesAgedAged, 80 and overAlcohol DrinkingCognitive DysfunctionCOVID-19FemaleHumansHypertensionIncidenceMaleNeurodegenerative DiseasesRisk FactorsSARS-CoV-2Severity of Illness IndexAPOE geneClinical featuresCognitive impairmentCOVID-19IncidenceMadridMortalityNursing homeOlder peopleRisk factorsVallecas Project

Identifiers

PMID33429394
PMCPMC7900450
OpenAlexW3119020940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.